InnoCan Pharma Corporation (CSE:INNO)

Canada flag Canada · Delayed Price · Currency is CAD
10.80
+0.61 (5.99%)
At close: Dec 5, 2025
-22.72%
Market Cap 48.59M
Revenue (ttm) 37.64M
Net Income (ttm) -4.50M
Shares Out 4.50M
EPS (ttm) -1.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,100
Average Volume 1,388
Open 10.15
Previous Close 10.19
Day's Range 10.01 - 10.80
52-Week Range 7.00 - 21.00
Beta -0.04
RSI 30.94
Earnings Date Nov 20, 2025

About InnoCan Pharma

InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. The company operates in two segments: Online Sales and Other Operations. It engages in the research and development of CBD loaded exosomes, as well as operates LPT CBD-loaded liposome platform that facilitates exact dosing and the prolonged and controlled release of CBD into the blood stream for e... [Read more]

Founded 2018
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol INNO
Full Company Profile

Financial Performance

In 2024, InnoCan Pharma's revenue was $29.44 million, an increase of 115.55% compared to the previous year's $13.66 million. Losses were -$1.83 million, -60.98% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.